HALOZYME THERAPEUTICS, INC. Annual Share-based Payment Arrangement, Expense in USD from 2010 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Halozyme Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2010 to 2024.
  • Halozyme Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2024 was $11.5M, a 18.6% increase year-over-year.
  • Halozyme Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2024 was $43.4M, a 18.5% increase year-over-year.
  • Halozyme Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $43.4M, a 18.5% increase from 2023.
  • Halozyme Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $36.6M, a 50.1% increase from 2022.
  • Halozyme Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $24.4M, a 17.2% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $43.4M +$6.77M +18.5% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-18
2023 $36.6M +$12.2M +50.1% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-18
2022 $24.4M +$3.58M +17.2% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-18
2021 $20.8M +$3.62M +21% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-20
2020 $17.2M -$17.6M -50.5% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-21
2019 $34.8M -$920K -2.58% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-22
2018 $35.7M +$5.03M +16.4% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-23
2017 $30.7M +$5.09M +19.9% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-24
2016 $25.6M +$4.75M +22.8% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-21
2015 $20.8M +$5.56M +36.4% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-20
2014 $15.3M +$5.74M +60.1% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-28
2013 $9.54M +$1.19M +14.2% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-29
2012 $8.35M +$2.78M +49.9% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-02
2011 $5.57M +$704K +14.5% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-28
2010 $4.87M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.